Last reviewed · How we verify

NCT05275764

Comparison of the Efficacy of Intraocular Lens Optic Capture and In-the-bag Implantation Over 1 Year in Children With Congenital Cataract

Status unknown Last updated 11 March 2022
What this trial tests

trial testing primary or secondary intraocular lens implantation surgery in Congenital Cataract in 30 participants. Status unknown.

Timeline
1 November 2021
Primary endpoint
30 June 2022
31 December 2022

Quick facts

Lead sponsorWenzhou Medical University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 November 2021
Primary completion30 June 2022
Estimated completion31 December 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Wenzhou Medical University

Who can join

Adults 1 to 10, any sex, with Congenital Cataract or Intraocular Lens Implantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Approximately 30 eyes with congenital cataract who underwent primary or secondary intraocular lens implantation surgery at Zhejiang Eye Hospital from March 2018 to December 2020 were enrolled. According to the implantation method of IOL, patients were devided into the optic capture group and the endocapsular group. And through the clinical parameters of postoperative best corrected visual acuity (BCVA), intraocular pressure (IOP), IOL position and whether appear visual axis opacity to compare the outcome of the 2 IOL implantation methods.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congenital Cataract

Currently open trials in the same condition.

Other Wenzhou Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05275764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing